icd9 code for metastatic nonsmall cell lung cancer

báo cáo hóa học: " Health state utilities for non small cell lung cancer" pot

báo cáo hóa học: " Health state utilities for non small cell lung cancer" pot

Ngày tải lên : 18/06/2014, 19:20
... state utilities for metastatic breast cancer. Br J Cancer 2006, 95(6):683-90. 17. Cancer Research UK [http://www.cancerresearchuk.org ] 18. Cancer Help [http://www.cancerhelp.org.uk ] 19. Association for ... of small cell and non-small cell lung cancer. University of Iowa Virtual Hos- pital; 1999. 6. Hopwood P, Stephens RJ: Symptoms at presentation for treat- ment in patients with lung cancer: Implications ... health state descriptions of metastatic breast cancer [16] to describe patients receiving second-line treatment for NSCLC. Health states developed for a study of metastatic breast cancer were adapted...
  • 15
  • 397
  • 0
Báo cáo khoa học: "Large volume unresectable locally advanced nonsmall cell lung cancer: acute toxicity and initial outcome results with rapid arc" potx

Báo cáo khoa học: "Large volume unresectable locally advanced nonsmall cell lung cancer: acute toxicity and initial outcome results with rapid arc" potx

Ngày tải lên : 09/08/2014, 09:20
... solid tumor. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United State, National Cancer Institute of Canada. J Natl Cancer Inst 2000, 92:205-216. 29. ... advanced lung cancer (stage III) with volumetric modulated arcs using RapidArc (RA). Methods: Twenty-four consecutive patients were treated with RA. All showed locally advanced non-small cell lung cancer ... remains the major cause of cancer- related mortality worldwide. Non-small cell lung cancer (NSCLC) account for at least 80% of all lung tumors and about 30% of them present with unresectable locally advanced...
  • 9
  • 265
  • 0
Báo cáo khoa học: " Validation of an elastic registration technique to estimate anatomical lung modification in NonSmall-Cell Lung Cancer Tomotherapy" docx

Báo cáo khoa học: " Validation of an elastic registration technique to estimate anatomical lung modification in NonSmall-Cell Lung Cancer Tomotherapy" docx

Ngày tải lên : 09/08/2014, 09:20
... number of cases could further reinforce our results. The good per- formance of our method suggests that it could be used effectively for the analysis of lung deformations in the context of HT NSCLC ... this work, we proposed and validated a method based on free-form deformation and mutual information to perform elastic registration for treatment planning kVCT images and daily MVCT images in ... 2004, 60(5):1639-1644. 3. Fox J, Ford E, Redmond K, Zhou J, Wong J, Song DY: Quantification of Tumor Volume Changes during Radiotherapy for Non-Small -Cell Lung Cancer. International Journal of...
  • 10
  • 358
  • 0
báo cáo hóa học:" Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer" docx

báo cáo hóa học:" Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer" docx

Ngày tải lên : 18/06/2014, 15:20
... Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94:153-156. 2. Non-small Cell Lung Cancer Collaborative Group: Chemotherapy in non small cell lung cancer: a meta-analysis ... cisplatin-teniposide in patients with advanced non-small -cell lung cancer. The European Organi- zation for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 1998, 16:2133-2141. 7. ... paclitaxel plus gemcitabine in advanced non-small- cell lung cancer: a phase III trial of the European Organiza- tion for Research and Treatment of Cancer Lung Cancer Group – EORTC 08975. J Clin Oncol...
  • 8
  • 538
  • 0
Báo cáo khoa học: "Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size" ppsx

Báo cáo khoa học: "Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size" ppsx

Ngày tải lên : 09/08/2014, 09:20
... hedules applied for SBRT for lung cancer varied greatly from institution to institution [10]. The most frequently used schedule was 48 Gy in 4 fractions for both stage IA and IB primary lung cancer and metastatic ... non-small -cell lung cancer: clinical implications. Radiother Oncol 2010, 94:1-11. 27. Chen Y, Guo W, Lu Y, Zou B: Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: ... non-small -cell lung cancer. Int J Radiat Oncol Biol Phys 2002, 52:382-389. 16. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R: The role of radiotherapy in treatment of stage I non-small cell lung cancer. ...
  • 7
  • 297
  • 0
Báo cáo khoa học: "Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study" pps

Báo cáo khoa học: "Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study" pps

Ngày tải lên : 09/08/2014, 09:22
... body radiotherapy for stage I non-small cell lung cancer. Radiother Oncol 2007, 85:429-434. 39. Sinha B, McGarry RC: Stereotactic body radiotherapy for bilat- eral primary lung cancers: the Indiana ... surgery in patients with operable lung cancer. A randomized phase III trial of Radiosurgery Or Surgery for operable Early stage (stage 1A) non-small cell Lung cancer (ROSEL, ClinicalTrials.gov ... the planning of stereotactic radiotherapy. Therefore, an additional planning study was performed in 22 stage IA and 4 stage 1B non-small cell lung cancer patients in order to develop and evaluate...
  • 14
  • 308
  • 0
Báo cáo khoa học: Epidermal growth factor receptor-regulated miR-125a-5p – a metastatic inhibitor of lung cancer potx

Báo cáo khoa học: Epidermal growth factor receptor-regulated miR-125a-5p – a metastatic inhibitor of lung cancer potx

Ngày tải lên : 07/03/2014, 00:20
... lung cancer samples Primary human lung cancers and paired noncancerous nor- mal lung samples were obtained from 15 patients treated at the Zhejiang Province Cancer Hospital, with documented informed ... the growth of PC9 cells and tube formation of ECV304 cells. (A) PC9 cells (5 · 10 3 ) cells were plated on 96-well plates. Forty-eight hours later, MTT was added to each well for 3 h at 37 °C, ... expression in lung cancer cells. (A) Western blot showed that, after EGF (20 ngặmL )1 ) stimulation, phosphorylation of EGFR, ERK1 ⁄ 2 and Akt occurred in PC9, A549 and H1299 lung cancer cells, and...
  • 8
  • 536
  • 0
Báo cáo hóa học: " Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer" pdf

Báo cáo hóa học: " Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer" pdf

Ngày tải lên : 18/06/2014, 16:20
... at 95°C for 10 min, and the cell extract submitted to PCR. DNA from the cell line PC-9 was used as a mutated control for exon 19, and wt control for exons 20 and 21. DNA from the H1975 cell line ... of detecting EGFR mutations in lung cancer patients. Methods: EGFR mutation status was analyzed by DNA assays, and compared with IHC results in five non-small -cell lung cancer (NSCLC) cell lines and tumor ... Non-small -cell lung cancer harbouring mutations in the EGFR kinase domain. Clin Transl Oncol 2010, 12:75-80. 9. Gazdar AF: Activating and resistance mutations of EGFR in non-small -cell lung cancer: ...
  • 8
  • 798
  • 0
Báo cáo hóa học: "Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins" ppt

Báo cáo hóa học: "Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins" ppt

Ngày tải lên : 18/06/2014, 16:20
... and for clinical-pathological reasons are often divided into two broad categories: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). All major histological types of lung cancer ... act as a risk marker of lung cancer in Taiwan. Cancer 2003, 97:1558-1563. 11. Klein F, Amin Kotb WF, Petersen I: Incidence of human papilloma virus in lung cancer. Lung Cancer 2009, 65:13-18. 12. ... and neck cancer. HPV has also been speculated to have a role in the pathogenesis of lung cancer. To validate the hypothesis of HPV involvement in small cell lung cancer pathogenesis we performed...
  • 11
  • 471
  • 0
Báo cáo hóa học: "Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization" pot

Báo cáo hóa học: "Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization" pot

Ngày tải lên : 18/06/2014, 16:20
... required for cancer cell growth. PLoS One 2008, 3:e2557. 16. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9:189-98. 17. ... marker expression in tumor cells versus stromal cells in non small cell lung cancer. Clin Cancer Res 2007, 13:6649-57. 24. World Health Organization: Histological Typing of Lung and Pleural Tumours. ... NSCLC. Introduction Lung cancer is the leading cause of cancer- related mor- tality in both men and women [1]. Despite several new treatment achievements, the consistently poor 5-year survival for lung cancer...
  • 9
  • 662
  • 0
Báo cáo toán học: "Molecular Predictors of EGFR-TKI Sensitivity in Advanced Non–small Cell Lung Cancer" ppsx

Báo cáo toán học: "Molecular Predictors of EGFR-TKI Sensitivity in Advanced Non–small Cell Lung Cancer" ppsx

Ngày tải lên : 08/08/2014, 17:20
... non-small cell lung cancer cell lines. Mol Cancer Res. 2006; 4(8): 521-8. 102. Taguchi F, Solomon B, Gregorc V, et al. Mass spectrometry to classify non-small -cell lung cancer patients for clinical ... death world- wide (1). Lung cancer is generally classified into two histological types, small cell lung cancer (SCLC) and non–small cell lung cancer (NSCLC). NSCLC accounts for approximately 85% ... non-small cell lung cancer Is correlated with survival. Clin Cancer Res. 2001; 7(7): 1850-5. 93. Cappuzzo F, Gregorc V, Rossi E, et al. Gefitinib in pretreated non-small -cell lung cancer (NSCLC):...
  • 9
  • 203
  • 0
Báo cáo khoa học: "Pathological complete response induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer" pptx

Báo cáo khoa học: "Pathological complete response induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer" pptx

Ngày tải lên : 09/08/2014, 03:21
... Carteni’ 1 Abstract Background: Defining the optimal treatment for patients with inoperable non small cell lung cancer (NSCLC), presenting with metastatic mediastinal lymph nodes, is challenging. Nevertheless, ... treatment. Introduction In non-small cell lung cancer (NSCLC), mediastinal lymphnode involvement comprises a wide spectrum of severity. In fact, while 9% of patients with IIIA-N2 NSCLC is candidate for surgery at ... considered to be t he first-line chemotherapy for non-operable patients with NSCLC. The search for either molecular or genetic mar- kers predictive for docetaxel sensiti vity might constitute future...
  • 4
  • 303
  • 0
Báo cáo khoa học: "Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy" pot

Báo cáo khoa học: "Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy" pot

Ngày tải lên : 09/08/2014, 08:23
... chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 2000, 48:89-94. 27. Yamada M, Kudoh S, Hirata K, Nakajima T, Yoshikawa J: Risk factors of pneumonitis following chemoradiotherapy for lung cancer. ... method for the management of unresectable locally advanced non- small cell lung cancer (NSCLC). Unfortunately, the longer survival is achieved at the price of greater toxicity of the lung and ... JD, Komaki R, Mohan R: Dose and volume reduction for normal lung using intensity- modulated radiotherapy for advanced-stage non-small -cell lung cancer. Int J Radiat Oncol Biol Phys 2004, 58:1258-1267. 21....
  • 8
  • 371
  • 0

Xem thêm